SCHEMBL13020672

SCHEMBL13020672

CCN(CC)P(O[C@H]1C(C)[C@@H](COP(C)(C)=O)O[C@H]1C)N(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020669 0.81 — —
SCHEMBL13020673 0.72 FBP1 (0.34) —
SCHEMBL13020666 0.69 — —
SCHEMBL13020671 0.68 FBP1 (0.43) —
SCHEMBL19051707 0.68 FGF1 (0.32) —
SCHEMBL13020665 0.67 — —
SCHEMBL19051708 0.64 FGF1 (0.30) —
SCHEMBL12354860 0.63 FBP1 (0.53) —
SCHEMBL26943038 0.63 FBP1 (0.53) —
SCHEMBL15624969 0.62 FBP1 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331397-A1 2-5A ANALOGS AND THEIR METHODS OF USE ALIOS BIOPHARMA, INC. (US) 2010-12-30 — — US disclosed
Send feedback